STATE STREET CORP - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$67,215,020
-49.4%
7,173,428
+32.4%
0.00%
-42.9%
Q2 2023$132,923,262
+6.1%
5,418,804
+0.6%
0.01%0.0%
Q1 2023$125,289,304
-54.8%
5,384,163
-50.8%
0.01%
-12.5%
Q4 2022$277,218,254
+146.6%
10,952,914
+87.9%
0.01%
+14.3%
Q3 2022$112,410,000
-20.0%
5,830,417
+5.6%
0.01%
-12.5%
Q2 2022$140,572,000
+30.3%
5,519,138
+31.6%
0.01%
+60.0%
Q1 2022$107,864,000
+1.9%
4,193,764
+65.9%
0.01%0.0%
Q4 2021$105,852,000
+6.3%
2,528,107
+10.5%
0.01%0.0%
Q3 2021$99,568,000
-2.1%
2,287,866
+6.3%
0.01%0.0%
Q2 2021$101,743,000
+5.6%
2,151,935
+14.5%
0.01%
-16.7%
Q1 2021$96,322,000
+22.5%
1,878,727
-36.0%
0.01%
+20.0%
Q4 2020$78,618,000
+146.6%
2,935,704
+216.1%
0.01%
+150.0%
Q3 2020$31,887,000
-6.8%
928,830
+11.2%
0.00%0.0%
Q2 2020$34,224,000
+690.2%
835,344
+561.0%
0.00%
Q1 2020$4,331,000
+744.2%
126,378
+210.1%
0.00%
Q4 2019$513,00040,7600.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
SB INVESTMENT ADVISERS (UK) LTD 22,616,666$284,405,0003.12%
INDUS CAPITAL PARTNERS, LLC 681,936$8,575,0001.68%
Alphabet Inc. 1,666,666$20,958,0001.27%
Temasek Holdings (Private) Ltd 5,499,999$69,162,0000.45%
Board of Trustees of The Leland Stanford Junior University 38,905$490,0000.06%
Baillie Gifford 500,000$6,287,0000.01%
Marshall Wace North America L.P. 74,898$941,0000.01%
Capital International Investors 983,300$12,365,0000.00%
Blackstone Inc. 35,000$440,0000.00%
Tower Research Capital LLC (TRC) 1,908$24,0000.00%
View complete list of VIR BIOTECHNOLOGY INC shareholders